1. Home
  2. RNXT vs OPTX Comparison

RNXT vs OPTX Comparison

Compare RNXT & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • OPTX
  • Stock Information
  • Founded
  • RNXT 2012
  • OPTX 1981
  • Country
  • RNXT United States
  • OPTX United States
  • Employees
  • RNXT N/A
  • OPTX N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • RNXT Health Care
  • OPTX Finance
  • Exchange
  • RNXT Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • RNXT 44.6M
  • OPTX 51.7M
  • IPO Year
  • RNXT 2021
  • OPTX N/A
  • Fundamental
  • Price
  • RNXT $1.30
  • OPTX $1.31
  • Analyst Decision
  • RNXT Strong Buy
  • OPTX
  • Analyst Count
  • RNXT 2
  • OPTX 0
  • Target Price
  • RNXT $7.25
  • OPTX N/A
  • AVG Volume (30 Days)
  • RNXT 135.9K
  • OPTX 59.0K
  • Earning Date
  • RNXT 08-12-2025
  • OPTX 08-13-2025
  • Dividend Yield
  • RNXT N/A
  • OPTX N/A
  • EPS Growth
  • RNXT N/A
  • OPTX N/A
  • EPS
  • RNXT N/A
  • OPTX 0.00
  • Revenue
  • RNXT $240,000.00
  • OPTX $29,392,186.00
  • Revenue This Year
  • RNXT $3,104.65
  • OPTX N/A
  • Revenue Next Year
  • RNXT $301.89
  • OPTX N/A
  • P/E Ratio
  • RNXT N/A
  • OPTX $787.20
  • Revenue Growth
  • RNXT N/A
  • OPTX 4.00
  • 52 Week Low
  • RNXT $0.75
  • OPTX $0.85
  • 52 Week High
  • RNXT $1.69
  • OPTX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 53.41
  • OPTX 42.53
  • Support Level
  • RNXT $1.29
  • OPTX $1.36
  • Resistance Level
  • RNXT $1.38
  • OPTX $1.39
  • Average True Range (ATR)
  • RNXT 0.07
  • OPTX 0.08
  • MACD
  • RNXT -0.01
  • OPTX 0.00
  • Stochastic Oscillator
  • RNXT 48.39
  • OPTX 27.27

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: